KETOGENIC THERAPY IN THE TREATMENT OF DISEASE
Recent scientific studies have demonstrated that a state of ketosis can aid in weight loss, improve brain function in Alzheimer’s and dementia patients, cause tumor regression, reduce epilepsy, and reverse Type 2 Diabetes.
Multiple diseases have been shown to respond to elevated levels of ketone bodies (or a state of ketosis). These diseases may be grossly defined by one of three categories:
- Problems generating energy from carbohydrates (brain dysfunction, epilepsy)
- Increased reactive oxygen species (ROS) (cancer, inflammation),
- Triggered by elevated insulin and blood glucose (cancer, diabetes).
Increased concentration of ketone bodies (i.e., beta hydroxybutyrate) can address these problems by replacing glucose as a primary source of energy and acting as a sink for oxidized species. The most common method of elevating ketone bodies is through carbohydrate restriction which can be achieved by eating a very low carbohydrate, high fat diet or fasting. Consistent restriction of carbohydrate restriction will cause insulin and blood glucose concentrations to decrease. The therapeutic concentration of ketone bodies depends on the disease and may depend on a multitude of factors including, age, gender, weight, diet, condition, and disease severity.
The ketone bodies provide a benefit through modification of mitochondrial energy production and indirectly through reduction of insulin and blood glucose. Measurement of ketosis is critical to verify that a therapeutic level of ketosis has been met. Frequent measurement of ketosis allows users to adjust and personalize their diet and behaviors to maintain therapeutic levels of ketosis.
For those trying to achieve therapeutic levels of ketosis to reduce disease progression, the ability to accurately measure ketones is critical. The LEVL device provides you with an accurate measurement of the ketone body – acetone – so you make real time choices about your wellness plan.